Nanjing Medlander Medical Technology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Medlander Medical Technology Co., Ltd.

Why is Nanjing Medlander Medical Technology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 10.70% and Operating profit at -1.27% over the last 5 years

Negative results in Mar 25

INTEREST(9M) At CNY 0.91 MM has Grown at 159.45%
DEBT-EQUITY RATIO (HY) Highest at -60.89 %

With ROE of 7.21%, it has a attractive valuation with a 0.68 Price to Book Value

Over the past year, while the stock has generated a return of 32.99%, its profits have risen by 27% ; the PEG ratio of the company is 0.4

Market Beating Performance

The stock has generated a return of 32.99% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Nanjing Medlander Medical Technology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nanjing Medlander Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Medlander Medical Technology Co., Ltd.

37.68%

1.44

52.33%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.70%

EBIT Growth (5y)

-1.27%

EBIT to Interest (avg)

72.17

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

0.27

Tax Ratio

12.71%

Dividend Payout Ratio

78.76%

Pledged Shares

Institutional Holding

ROCE (avg)

29.08%

ROE (avg)

7.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.68

EV to EBIT

1.81

EV to EBITDA

1.30

EV to Capital Employed

0.25

EV to Sales

0.33

PEG Ratio

0.35

Dividend Yield

ROCE (Latest)

13.82%

ROE (Latest)

7.21%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

NET SALES(HY)

At CNY 210 MM has Grown at 37.39%

ROCE(HY)

Highest at 7.73%

RAW MATERIAL COST(Y)

Fallen by -0.88% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.37%

DEBTORS TURNOVER RATIO(HY)

Highest at 18.33%

PRE-TAX PROFIT(Q)

Highest at CNY 43.27 MM

NET PROFIT(Q)

Highest at CNY 39.27 MM

EPS(Q)

Highest at CNY 0.4

-10What is not working for the Company

INTEREST(9M)

At CNY 0.91 MM has Grown at 159.45%

DEBT-EQUITY RATIO (HY)

Highest at -60.89 %

Here's what is working for Nanjing Medlander Medical Technology Co., Ltd.

Net Sales

At CNY 210 MM has Grown at 37.39%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 43.27 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 39.27 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.4

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 2.37%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 18.33%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -0.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Medlander Medical Technology Co., Ltd.

Interest

At CNY 0.59 MM has Grown at 135.53%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -60.89 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio